Concurrent chemo-radiotherapy

RADIATION4 trials

Sponsors

Harbin Medical University, Huazhong University of Science and Technology, Sun Yat-sen University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions

Cervical CarcinomaChemotherapyGastric CancerNasopharyngeal CarcinomaPD-1 TreatmentRadiotherapyRectum Cancer

Phase 2

Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

Not yet recruitingNCT07088731

Cancer Institute and Hospital, Chinese Academy of Medical SciencesCervical Carcinoma

Start: 2025-09-30End: 2027-07-31Target: 180Updated: 2025-09-22

Phase 3

Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer

Huazhong University of Science and TechnologyGastric Cancer

Start: 2018-07-28End: 2022-07-28Target: 408Updated: 2018-07-26

Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

RecruitingNCT04453813

Sun Yat-sen UniversityChemotherapy, Nasopharyngeal Carcinoma, PD-1 Treatment +1

Start: 2020-07-03End: 2027-07-31Target: 226Updated: 2020-09-28

Unknown Phase

Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy

Harbin Medical UniversityRectum Cancer

Start: 2017-03-01End: 2021-09-30Target: 1Updated: 2017-03-07